BIOL Historical Earnings image   This BIOL historical earnings page last updated 11/11/2022
BIOL Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/10/20220.01B
Q2 20228/11/20220.01B
Q1 20225/12/20220.01B
Q4 20213/17/20220.01B
Q3 202111/10/20210.01B
Q2 20218/12/20210.01B
Q1 20215/13/20210.01B
Q4 20203/25/20210.01B
Q3 202011/12/20200.01B
Q2 20208/13/20200.00B
Q1 20205/7/20200.00B
Q4 20193/26/20200.01B
Q3 201911/6/20190.01B
Q2 20198/8/20190.01B
Q1 20195/9/20190.01B
Q4 20183/5/201913.04M
Q3 201811/13/201810.94M
Q2 20188/8/201812.15M
Q1 20185/2/201810.02M
Q4 20173/14/201812.63M
Q3 201711/1/201710.81M
Q2 20178/7/201712.61M
Q1 20175/3/201710.87M
Q4 20163/8/201713.76M
Q3 201611/8/201613.23M
Q2 20168/1/201613.81M
Q1 20165/9/201611.01M
Q4 20153/9/201614.52M
Q3 201511/4/201511.23M
Q2 20158/5/201511.87M
Q1 20154/30/201510.86M
Q4 20143/4/201513.24M
Q3 201411/4/201412.70M
Q2 20148/7/201410.20M
Q1 20145/12/201411.50M
Q4 20133/5/201415.20M
Q3 201311/11/201312.30M
Q2 20138/7/201314.20M
Q1 20135/7/201314.60M
Q4 20123/6/201319.10M
Q3 201211/5/201213.78M
Q2 20128/8/20120.01B
BIOL Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/10/2022-1.100
Q2 20228/11/2022-0.910
Q1 20225/12/2022-0.770
Q4 20213/17/2022-0.750
Q3 202111/10/2021-0.500
Q2 20218/12/2021-0.500
Q1 20215/13/2021-1.500
Q4 20203/25/2021-1.750
Q3 202011/12/2020-5.250
Q2 20208/13/2020-3.000
Q1 20205/7/2020-4.750
Q4 20193/26/2020-3.250
Q3 201911/6/2019-6.250
Q2 20198/8/2019-3.250
Q1 20195/9/2019-3.750
Q4 20183/5/2019-3.250
Q3 201811/13/2018-4.750
Q2 20188/8/2018-5.000
Q1 20185/2/2018-1.000
Q4 20173/14/2018-1.000
Q3 201711/1/2017-1.250
Q2 20178/7/2017-1.250
Q1 20175/3/2017-1.250
Q4 20163/8/2017-1.250
Q3 201611/8/2016-1.000
Q2 20168/1/2016-1.000
Q1 20165/9/2016-1.500
Q4 20153/9/2016-0.500
Q3 201511/4/2015-2.000
Q2 20158/5/2015-2.500
Q1 20154/30/2015-0.08
Q4 20143/4/2015-0.06
Q3 201411/4/2014-0.07
Q2 20148/7/2014-0.17
Q1 20145/12/2014-0.11
Q4 20133/5/2014-0.04
Q3 201311/11/2013-0.1
Q2 20138/7/2013-0.06
Q1 20135/7/2013-0.06
Q4 20123/6/20130.03
Q3 201211/5/2012-0.02
Q2 20128/8/2012-0.04
Quotes delayed 20 minutes

Email EnvelopeFree BIOL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biolase (BIOL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BIOR Historical Earnings
BIVI Historical Earnings
BKD Historical Earnings
BLCM Historical Earnings
BLFS Historical Earnings
BLI Historical Earnings
BLPH Historical Earnings
BLUE Historical Earnings
BMEA Historical Earnings
BMRA Historical Earnings
What was the record high BIOL historical earnings result?
In terms of earnings or revenue, what is the best BIOL historical earnings result that Biolase has ever posted, and when?

✔️Accepted answer: Within our data set, the highest BIOL historical earnings result was set in Q4 2012, when Biolase posted results of 0.03/share. The most successful revenue quarter within our data set was Q4 2012 when Biolase reported revenue of 19.10M.

What was the lowest Biolase historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest BIOL has reported, and when?

✔️Accepted answer: Within our data set, the lowest BIOL historical earnings result was set in Q3 2019, when Biolase posted results of -6.250/share. The smallest revenue quarter within our data set was Q2 2020 when Biolase reported revenue of 0.00B.

On this page we presented the BIOL historical earnings date information for Biolase. Reviewing that BIOL Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2012, when BIOL posted gaap of 0.03/share. Meanwhile the lowest BIOL historical earnings result was in Q3 2019, when BIOL posted gaap of -6.250/share. Moving to Biolases historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2012 when BIOL reported 19.10M in revenue, while the smallest revenue quarter was Q2 2020 when BIOL reported 0.00B in revenue.

For self directed investors doing their due diligence on BIOL or any other given stock, their research can benefit from looking into all of the Biolase historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Biolase historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for BIOL. Thanks for visiting, and the next time you need to research BIOL historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding CBNJ, Institutional Holders of ACUR, UYM market cap history.


BIOL Historical Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.